Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab
BLOOD CANCER JOURNAL(2020)
关键词
B-cell lymphoma,Chronic lymphocytic leukaemia,Biomedicine,general,Cancer Research,Oncology,Hematology
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要